Searchable abstracts of presentations at key conferences in endocrinology

ea0063mte11 | (1) | ECE2019

‘Shifting treatment paradigms in osteoporosis’.

Guananens Nuria

In recent years a number of paradigms have changed the way we go about therapy and its monitoring. So, what has changed? Bisphosphonates were until recently the cornerstone of osteoporosis treatment, but in the last few years new drugs and treatment concepts have appeared. Thus, anabolics such as teriparatide are established as the gold standard in patients with high risk of vertebral fractures. In addition, monoclonal antibodies against bone turnover regulators such as denosu...